4, 5-dihydro-oxazol-2-yl amine derivatives

Details for Australian Patent Application No. 2009216825 (hide)

Owner F. Hoffmann-La Roche AG Siena Biotech S.p.A

Inventors Andreini, Matteo; Travagli, Massimiliano; Power, Eoin; Narquizian, Robert; Wostl, Wolfgang; Woltering, Thomas; Guba, Wolfgang; Gabellieri, Emanuele; Marconi, Guido

Agent Spruson & Ferguson

Pub. Number AU-A-2009216825

PCT Pub. Number WO2009/103626

Priority 08151546.2 18.02.08 EP

Filing date 9 February 2009

Wipo publication date 27 August 2009

International Classifications

C07D 263/28 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/103626 Priority application(s): WO2009/103626

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009216829-Method for providing an insulated electric high voltage DC cable or a high voltage DC termination or joint

2009216788-Gas turbine having an improved cooling architecture